Replies to post #43499 on NorthWest Biotherapeutics Inc (NWBO)

[Diamondjim61]

Great sleuth work Follower!

I made an assumption that NW had a relationship with Ondra, and now you proved it. I think this is a great thing for Northwest and may change the light they are viewed in once Ondra is fully integrated and running with the ball.

[rrflyboy]

Good research, well done. Thank you.

[maverick_1]

Super Follow Up on Ondra & as for FD on Priv. Placement

Actually as it concerns BOTH of above matters have not thought twice above pursuing either given the rather
unusual "intimate developing long term relationship with the size and frequency of transactions between the parties .

Boiling it down, I distinctly recall Sir Neil Woodford as the key spokesman nationally against PFE's CEO Ian Reed overtures to acquiring AZ. That and how he explicitly deals with his flock of positions clearly surmounts all given his record of high profile achievements with giant Invesco Funds. Really hard to imagine anything not being thoroughly vetted out to withstand whatever barriers.

[Evaluate]

I would not be surprised in Michael Baldock is the main lead for the new NWBO engagement.

http://www.ondra.com/our-people
includes:

Michael Baldock
American
Seasoned corporate finance and M&A practitioner with broad industrial experience and a special interest in the healthcare industry.

http://thetally.efinancialnews.com/2014/01/250m-biotech-deal-stands-crowd/
includes:

It also extended lengthy relationships for the advisory specialist Ondra Partners. The firm is the retained advisor to Alkermes, with US-based partner Michael Baldock leading.